TGFB1 and glaucoma: In addition, it has been evaluated as a postoperative anti-scarring agent for use in glaucoma surgery in a lagomorph model, and it was recently reported to successfully inhibit TGF-β1-induced equine corneal fibrosis in vitro [66,67].